On Monday, March 27, 2023, Ohio Attorney General Dave Yost sued pharmacy benefit managers (PBMs) from multiple organizations for collusion on drug prices. The lawsuit names numerous defendants,...
On Wednesday, March 1, 2023, Eli Lilly, a major insulin manufacturer in the United States, announced that it would cut its insulin prices by 70% and cap out-of-pocket costs to $35 per month. By the end...
In January of this year, 46brooklyn, an Ohio-based nonprofit focusing on drug pricing data in the United States, revealed its annual drug pricing data report for 2023. The organization uses and analyzes proprietary data to help shed light...
An investigation published in JAMA Internal Medicine assessed FDA-approved drugs and regulatory decisions made in other countries. In particular, the study focused on regulation and health technology...
On January 31, 2023, Amgen announced that its product AMJEVITA, a Humira biosimilar, is now available in the United States. This new availability threatens the stake that AbbVie has held for decades...
In a recent press release, GoodRx, a digital healthcare platform, launched Provider Mode. Provider Mode is a new experience that is specifically targeted to healthcare professionals (HCPs). PharmaNewsIntelligence interviewed Preeti Parikh,...
As the COVID-19 pandemic progresses, access and affordability to vaccines have been effective tools for public health professionals. Currently, the federal government covers COVID-19 vaccination...
In a recent analysis written by José R. Guardado, PhD, for the AMA, he analyzed the competition against drug intermediaries, referred to as pharmacy benefit managers (PBMs). In the report,...
On Thursday of last week, the US Supreme Court (SCOTUS) allowed the launch of generic versions of Novartis’s Gilenya, siding with China’s HEC Pharm Co and other pharmaceutical companies...
On October 3, 2022, the FDA awarded the Biologics and Biosimilars Collective Intelligence (BBIC) a $1.3 million grant to be paid out in the next two years. The grant is intended to fund a study on...
It’s no secret that drug costs in the United States have continued to increase in the past few years. The Kaiser Family Foundation states that between 2019 and 2022, 48% of prescription drugs had...
The United Network for Organ Sharing (UNOS) states that, as of July 2022, there have been 24,414 organ transplants this year in the United States alone. Considering the limitations on the number of organs available for transplant and the...
The FDA approval process is complex and involves multiple steps. Understanding how a prescription drug becomes available over the counter (OTC) is essential for healthcare professionals, members of the pharmaceutical industry, and...
On Monday, September 19, McKesson announced that it had signed an agreement with Rx Savings Solutions. This agreement focuses on the company’s plans to acquire Rx Savings Solutions to advance the...
Chemotherapy drugs play a significant role in the treatment of cancer. Understanding the kinds of chemotherapy drugs can help patients make an informed decision with the assistance of their oncologist and their team of healthcare...
In recent years, the costs of prescription drugs have increased dramatically. One of the most notable drugs with high prices is insulin. Understanding the basic uses of insulin and common delivery methods may contribute to an in-depth...
According to the CDC, patients with type one diabetes have a pancreas that produces no or little insulin. To properly manage the disease, many patients take insulin. With the price of insulin rising,...
In the United States, drug prices have soared in recent years. The pharmaceutical industry and medicine, in general, have been criticized for these rising drug costs. Beyond the associated financial burden, inflated medication costs also...
In one decade, brand-name epilepsy drug prices have increased by 277%, according to a recent press release by the American Academy of Neurology. This review looked at data from Medicare patients...
From 2015 to 2019, median prescription drug manufacturer pre-rebate costs per covered life (PCL) increased by 68.1% for individual plans, 44.9% for small group plans, and 23.9% for large group plans,...
